RCUS logo

Arcus Biosciences (RCUS) Net Income

Annual Net Income

-$283.00 M
+$24.00 M+7.82%

December 31, 2024

Summary

Performance

1-Year Change

+7.82%

3-Year Change

-633.96%

5-Year Change

-234.08%

15-Year Change

-433.14%

RCUS Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.23%
RCUS annual net profit is higher than 6.23% of companies in Healthcare sector

High & Low

All-time High

$53.00 M
RCUS annual net profit is currently -633.96% below its historical high of $53.00 million

3-Year Low

-$307.00 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
RCUS previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
RCUS next annual earnings announcement has not yet been scheduled

OtherRCUSprofitabilitymetrics:

Annual Net Margin

-109.69%
RCUS annual net profit margin is -109.69%

Annual Revenue

$258.00 M
RCUS annual revenue is $258.00 million

Annual Gross Profit

-
RCUS annual gross profit value is unknown

Annual EPS

-$3.14
RCUS annual earnings per share is -$3.14

Quarterly Net Income

-$94.00 M
-$2.00 M-2.17%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

-16.05%

3-Year Change

-133.63%

5-Year Change

-466.33%

RCUS Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.78%
RCUS quarterly net profit is higher than 4.78% of companies in Healthcare sector

High & Low

All-time High

$279.54 M
RCUS quarterly net profit is currently -133.63% below its historical high of $279.54 million

3-Year Low

-$94.00 M
RCUS quarterly net profit is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUSprofitabilitymetrics:

Quarterly Net Margin

-361.54%
RCUS quarterly net profit margin is -361.54%

Quarterly Revenue

$26.00 M
RCUS quarterly revenue is $26.00 million

Quarterly Gross Profit

-
RCUS quarterly gross profit value is unknown

Quarterly EPS

-$1.03
RCUS quarterly earnings per share is -$1.03

TTM Net Income

-$283.00 M
-$13.00 M-4.81%

December 31, 2024

Summary

Performance

3-Month Change

0%

1-Year Change

+7.82%

3-Year Change

-633.96%

5-Year Change

-234.08%

RCUS TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

6.66%
RCUS TTM net profit is higher than 6.66% of companies in Healthcare sector

High & Low

All-time High

$79.54 M
RCUS TTM net profit is currently -455.80% below its historical high of $79.54 million

3-Year Low

-$307.00 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
RCUS previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 8, 2025
RCUS next earnings announcement is scheduled for May 8, 2025

OtherRCUSprofitabilitymetrics:

Annual Net Margin

-109.69%
RCUS annual net profit margin is -109.69%

TTM Revenue

$258.00 M
RCUS TTM revenue is $258.00 million

TTM Gross Profit

-
RCUS TTM gross profit value is unknown

TTM EPS

-$3.10
RCUS TTM earnings per share is -$3.10

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$283.00 M
RCUS annual net profit is -$283.00 million

Annual Revenue

$258.00 M
RCUS annual revenue is $258.00 million

Annual Cost Of Goods Sold

-
RCUS annual cost of goods sold value is unknown

Annual Operating Expenses

$568.00 M
RCUS annual total operating expenses is $568.00 million

Annual Interest Expense

$4.00 M
RCUS annual interest expense is $4.00 million

Annual Income Tax

$1.00 M
RCUS annual income tax is $1.00 million

RCUS Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+7.8%-16.1%+7.8%
3 y3 years-634.0%-133.6%-634.0%
5 y5 years-234.1%-466.3%-234.1%

RCUS Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-634.0%+7.8%-133.6%at low-455.8%+7.8%
5 y5-year-634.0%+7.8%-133.6%at low-455.8%+7.8%
alltimeall time-634.0%+7.8%-133.6%at low-455.8%+7.8%

Arcus Biosciences Net Income History

DateAnnualQuarterlyTTM
Dec 2024
-$283.00 M(-7.8%)
-$94.00 M(+2.2%)
-$283.00 M(+4.8%)
Sep 2024
-
-$92.00 M(-1.1%)
-$270.00 M(+8.4%)
Jun 2024
-
-$93.00 M(+2225.0%)
-$249.00 M(+7.8%)
Mar 2024
-
-$4.00 M(-95.1%)
-$231.00 M(-24.8%)
Dec 2023
-$307.00 M(+15.0%)
-$81.00 M(+14.1%)
-$307.00 M(+4.8%)
Sep 2023
-
-$71.00 M(-5.3%)
-$293.00 M(+2.1%)
Jun 2023
-
-$75.00 M(-6.3%)
-$287.00 M(+2.9%)
Mar 2023
-
-$80.00 M(+19.4%)
-$279.00 M(+4.5%)
Dec 2022
-$267.00 M(-603.8%)
-$67.00 M(+3.1%)
-$267.00 M(-435.7%)
Sep 2022
-
-$65.00 M(-3.0%)
$79.54 M(+19.5%)
Jun 2022
-
-$67.00 M(-1.5%)
$66.56 M(+15.6%)
Mar 2022
-
-$68.00 M(-124.3%)
$57.59 M(+8.7%)
Dec 2021
$53.00 M(-143.1%)
$279.54 M(-458.5%)
$53.00 M(-119.0%)
Sep 2021
-
-$77.97 M(+2.6%)
-$278.53 M(+40.2%)
Jun 2021
-
-$75.97 M(+4.7%)
-$198.74 M(+18.4%)
Mar 2021
-
-$72.59 M(+39.6%)
-$167.84 M(+36.5%)
DateAnnualQuarterlyTTM
Dec 2020
-$123.00 M(+45.2%)
-$51.99 M(-2953.7%)
-$123.00 M(+40.4%)
Sep 2020
-
$1.82 M(-104.0%)
-$87.60 M(-21.6%)
Jun 2020
-
-$45.07 M(+62.4%)
-$111.78 M(+17.9%)
Mar 2020
-
-$27.75 M(+67.2%)
-$94.79 M(+11.9%)
Dec 2019
-$84.71 M(+70.8%)
-$16.60 M(-25.7%)
-$84.71 M(+5.4%)
Sep 2019
-
-$22.35 M(-20.4%)
-$80.41 M(+16.8%)
Jun 2019
-
-$28.09 M(+59.0%)
-$68.87 M(+26.8%)
Mar 2019
-
-$17.67 M(+43.7%)
-$54.31 M(+9.5%)
Dec 2018
-$49.59 M(-6.6%)
-$12.29 M(+13.7%)
-$49.59 M(-1.8%)
Sep 2018
-
-$10.81 M(-20.1%)
-$50.51 M(-19.6%)
Jun 2018
-
-$13.53 M(+4.5%)
-$62.82 M(+6.8%)
Mar 2018
-
-$12.95 M(-1.9%)
-$58.84 M(+10.8%)
Dec 2017
-$53.08 M(+195.4%)
-$13.21 M(-42.9%)
-$53.08 M(+33.1%)
Sep 2017
-
-$23.12 M(+142.1%)
-$39.87 M(+138.0%)
Jun 2017
-
-$9.55 M(+32.6%)
-$16.75 M(+132.6%)
Mar 2017
-
-$7.20 M
-$7.20 M
Dec 2016
-$17.97 M
-
-

FAQ

  • What is Arcus Biosciences annual net profit?
  • What is the all time high annual net income for Arcus Biosciences?
  • What is Arcus Biosciences annual net income year-on-year change?
  • What is Arcus Biosciences quarterly net profit?
  • What is the all time high quarterly net income for Arcus Biosciences?
  • What is Arcus Biosciences quarterly net income year-on-year change?
  • What is Arcus Biosciences TTM net profit?
  • What is the all time high TTM net income for Arcus Biosciences?
  • What is Arcus Biosciences TTM net income year-on-year change?

What is Arcus Biosciences annual net profit?

The current annual net income of RCUS is -$283.00 M

What is the all time high annual net income for Arcus Biosciences?

Arcus Biosciences all-time high annual net profit is $53.00 M

What is Arcus Biosciences annual net income year-on-year change?

Over the past year, RCUS annual net profit has changed by +$24.00 M (+7.82%)

What is Arcus Biosciences quarterly net profit?

The current quarterly net income of RCUS is -$94.00 M

What is the all time high quarterly net income for Arcus Biosciences?

Arcus Biosciences all-time high quarterly net profit is $279.54 M

What is Arcus Biosciences quarterly net income year-on-year change?

Over the past year, RCUS quarterly net profit has changed by -$13.00 M (-16.05%)

What is Arcus Biosciences TTM net profit?

The current TTM net income of RCUS is -$283.00 M

What is the all time high TTM net income for Arcus Biosciences?

Arcus Biosciences all-time high TTM net profit is $79.54 M

What is Arcus Biosciences TTM net income year-on-year change?

Over the past year, RCUS TTM net profit has changed by +$24.00 M (+7.82%)